230. cited by applicant . Alpharma Pharmaceuticals, "ALO-01 (Morphine Sulphate Extended-Release with Sequestered Naltrexone Hydrochloride) Capsules for the Management of Moderate to Severe Pain when a Continuous, Around-the-Clock Opioid Analgesic is Needed for an Extended Period of Time," Meeting of the Anesthetic and Life Support Drugs Advisory Committee, Nov. 14, 2008. cited by applicant . Johnson et al., "Morphine release profile in a formulation containing polymer-coated extended-release morphine sulfate plus sequestered naltrexone," J Pain, 2007, S40, Abstract 757. cited by applicant . Accelerated Examination Support Document for Petition to Make Special under Accelerated Examination Program filed in U.S. Appl. No. 12/399,923 on Mar. 6, 2009. cited by applicant . Bodmeier et al., "The Influence of Buffer Species and Strength on Diltiazem HCI Release from Beads Coated with the Aqueous Cationic Polymer Dispersions, Eudragit RS, RL 30D," Pharmaceutical Research, vol. 13, No. 1 (1996), pp. 52-56. cited by applicant . Knop et al., "Influence of surfactants of different charge and concentration on drug release from pellets coated with an aqueous dispersion of quaternary acrylic polymers," S.T.P. Pharma Sciences 7 (6) (1997), pp. 507-512. cited by applicant . Felton et al., "Influence of Insoluable Excipients on Film Coating Systems," Drug Development and Industrial Pharmacy, 28 (3) (2002), pp. 225-243. cited by applicant . Wagner et al., "Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films," Journal of Controlled Release, 82 (2002), pp. 385-397. cited by applicant . Pakkanen, Jukka S., "Academic Dissertation: Upregulation and Functionality of Neuronal Nicotinic Acetylcholine Receptors," Division of Pharmacology and Toxicology, Faculty of Pharmacy, University of Helsinki, (2006). cited by applicant . Notice of Opposition issued in connection with corresponding Pakistan Patent No. 140 330 on Jun. 9, 2010. cited by applicant . English Translation of the Office Action dated Feb. 1, 2008, in corresponding Ukrainian application No. 200511009. cited by applicant . English Translation of the Office Action dated Apr. 27, 2007, in corresponding Russian Application No. 200501586. cited by applicant . Counter-Statement filed in connection with corresponding Pakistan Application No. 277/2004 on Aug. 7, 2010. cited by applicant . European Search Report issued in connection with corresponding European application No. 10 001 414.1 dated Sep. 16, 2010. cited by applicant . Summons to attend oral proceedings pursuant to Rule 115(1) EPC issued on Aug. 23, 2012, in connection with European Application No. 04759980.8-1216. cited by applicant . Communication of Notice of Opposition dated Jan. 5, 2011, in connection with European Patent Application No. 04759980.8. cited by applicant . English Translation of the Opposition Brief filed by ACINO Pharma AG on Nov. 24, 2011, in connection with European Patent Application No. 04759980.8, the Opposition Brief included with the Communication of Notice of Opposition issued on Jan. 5, 2011 in connection with European Patent Application No. 04759980.8 (document A18). cited by applicant. Primary Examiner: Wax; Robert A Assistant Examiner: Singh; Randeep Attorney, Agent or Firm: Davidson, Davidson & Kappel, LLC